APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enzalutamide Drugs Market Analysis and Forecast 2026-2032

27 December 2025203 pages

Choose your research edition.

Industry ResearchEnzalutamide Drugs Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Enzalutamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Drugs Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enzalutamide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enzalutamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enzalutamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enzalutamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enzalutamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Enzalutamide Drugs include Yichang Humanwell Pharmaceutical, Shenyang Hongqi Pharmaceutical, PuraCap Pharmaceuticals, Qilu Pharmaceutical, Kelun Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Zydus, Sun Pharma and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enzalutamide Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enzalutamide Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Enzalutamide Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enzalutamide Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enzalutamide Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enzalutamide Drugs sales, projected growth trends, production technology, application and end-user industry.

Enzalutamide Drugs Segment by Company

Yichang Humanwell Pharmaceutical

Shenyang Hongqi Pharmaceutical

PuraCap Pharmaceuticals

Qilu Pharmaceutical

Kelun Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Zydus

Sun Pharma

Pfizer

Intas Pharmaceuticals

Glenmark Pharma

Beacon pharma

BDR Pharma

Astellas Pharma

Arechar Healthcare

Aprazer Healthcare Pharma

Abbott Laboratories

Enzalutamide Drugs Segment by Type

Tablets

Capsules

Enzalutamide Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enzalutamide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enzalutamide Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enzalutamide Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzalutamide Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enzalutamide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Global Enzalutamide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Other Major Manufacturers Table 8. Enzalutamide Drugs Industry Trends Table 9. Enzalutamide Drugs Industry Drivers Table 10. Enzalutamide Drugs Industry Opportunities and Challenges Table 11. Enzalutamide Drugs Industry Restraints Table 12. Global Enzalutamide Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Enzalutamide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Enzalutamide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Enzalutamide Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Enzalutamide Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Enzalutamide Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Enzalutamide Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Enzalutamide Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Enzalutamide Drugs Sales Market Share by Region (2021-2026) Table 21. Global Enzalutamide Drugs Sales Market Share by Region (2027-2032) Table 22. Global Enzalutamide Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Enzalutamide Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Enzalutamide Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Enzalutamide Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Enzalutamide Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Enzalutamide Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Enzalutamide Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Enzalutamide Drugs Manufacturers, Product Type & Application Table 30. Global Enzalutamide Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Enzalutamide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Enzalutamide Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Enzalutamide Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Enzalutamide Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Enzalutamide Drugs Sales Market Share by Type (2021-2026) Table 42. Global Enzalutamide Drugs Sales Market Share by Type (2027-2032) Table 43. Global Enzalutamide Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Enzalutamide Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Enzalutamide Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Enzalutamide Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Enzalutamide Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Enzalutamide Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Enzalutamide Drugs Sales Market Share by Application (2021-2026) Table 54. Global Enzalutamide Drugs Sales Market Share by Application (2027-2032) Table 55. Global Enzalutamide Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enzalutamide Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Yichang Humanwell Pharmaceutical Company Information Table 58. Yichang Humanwell Pharmaceutical Business Overview Table 59. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio Table 61. Yichang Humanwell Pharmaceutical Recent Development Table 62. Shenyang Hongqi Pharmaceutical Company Information Table 63. Shenyang Hongqi Pharmaceutical Business Overview Table 64. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio Table 66. Shenyang Hongqi Pharmaceutical Recent Development Table 67. PuraCap Pharmaceuticals Company Information Table 68. PuraCap Pharmaceuticals Business Overview Table 69. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio Table 71. PuraCap Pharmaceuticals Recent Development Table 72. Qilu Pharmaceutical Company Information Table 73. Qilu Pharmaceutical Business Overview Table 74. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio Table 76. Qilu Pharmaceutical Recent Development Table 77. Kelun Pharmaceutical Company Information Table 78. Kelun Pharmaceutical Business Overview Table 79. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio Table 81. Kelun Pharmaceutical Recent Development Table 82. Jiangsu Hansoh Pharmaceutical Company Information Table 83. Jiangsu Hansoh Pharmaceutical Business Overview Table 84. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio Table 86. Jiangsu Hansoh Pharmaceutical Recent Development Table 87. Zydus Company Information Table 88. Zydus Business Overview Table 89. Zydus Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zydus Enzalutamide Drugs Product Portfolio Table 91. Zydus Recent Development Table 92. Sun Pharma Company Information Table 93. Sun Pharma Business Overview Table 94. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sun Pharma Enzalutamide Drugs Product Portfolio Table 96. Sun Pharma Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer Enzalutamide Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. Intas Pharmaceuticals Company Information Table 103. Intas Pharmaceuticals Business Overview Table 104. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio Table 106. Intas Pharmaceuticals Recent Development Table 107. Glenmark Pharma Company Information Table 108. Glenmark Pharma Business Overview Table 109. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Glenmark Pharma Enzalutamide Drugs Product Portfolio Table 111. Glenmark Pharma Recent Development Table 112. Beacon pharma Company Information Table 113. Beacon pharma Business Overview Table 114. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Beacon pharma Enzalutamide Drugs Product Portfolio Table 116. Beacon pharma Recent Development Table 117. BDR Pharma Company Information Table 118. BDR Pharma Business Overview Table 119. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. BDR Pharma Enzalutamide Drugs Product Portfolio Table 121. BDR Pharma Recent Development Table 122. Astellas Pharma Company Information Table 123. Astellas Pharma Business Overview Table 124. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Astellas Pharma Enzalutamide Drugs Product Portfolio Table 126. Astellas Pharma Recent Development Table 127. Arechar Healthcare Company Information Table 128. Arechar Healthcare Business Overview Table 129. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Arechar Healthcare Enzalutamide Drugs Product Portfolio Table 131. Arechar Healthcare Recent Development Table 132. Aprazer Healthcare Pharma Company Information Table 133. Aprazer Healthcare Pharma Business Overview Table 134. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio Table 136. Aprazer Healthcare Pharma Recent Development Table 137. Abbott Laboratories Company Information Table 138. Abbott Laboratories Business Overview Table 139. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Abbott Laboratories Enzalutamide Drugs Product Portfolio Table 141. Abbott Laboratories Recent Development Table 142. North America Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 145. North America Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 146. North America Enzalutamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 147. North America Enzalutamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 148. North America Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 151. North America Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 152. North America Enzalutamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 153. North America Enzalutamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 154. North America Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Enzalutamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Enzalutamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. North America Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 159. North America Enzalutamide Drugs Sales by Country (2027-2032) & (K Units) Table 160. North America Enzalutamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 161. North America Enzalutamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 162. United States Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 163. Canada Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 164. Mexico Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 165. Europe Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 168. Europe Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 169. Europe Enzalutamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Europe Enzalutamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Europe Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 174. Europe Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 175. Europe Enzalutamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Europe Enzalutamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Europe Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Enzalutamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Enzalutamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Europe Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 182. Europe Enzalutamide Drugs Sales by Country (2027-2032) & (K Units) Table 183. Europe Enzalutamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Europe Enzalutamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Germany Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 186. France Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 187. U.K. Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 188. Italy Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 189. Russia Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 190. Spain Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 193. Sweden Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 194. Poland Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 195. China Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 196. China Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 197. China Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 198. China Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 199. China Enzalutamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 200. China Enzalutamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 201. China Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. China Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. China Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 204. China Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 205. China Enzalutamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 206. China Enzalutamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 210. Asia Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 211. Asia Enzalutamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 212. Asia Enzalutamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 213. Asia Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 216. Asia Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 217. Asia Enzalutamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 218. Asia Enzalutamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 219. Asia Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Enzalutamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Enzalutamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. Asia Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 224. Asia Enzalutamide Drugs Sales by Country (2027-2032) & (K Units) Table 225. Asia Enzalutamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 226. Asia Enzalutamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 227. Japan Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 228. South Korea Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 229. India Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 230. Australia Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Enzalutamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Enzalutamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 236. SAMEA Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 237. SAMEA Enzalutamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 238. SAMEA Enzalutamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 239. SAMEA Enzalutamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Enzalutamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 242. SAMEA Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 243. SAMEA Enzalutamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 244. SAMEA Enzalutamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 245. SAMEA Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Enzalutamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Enzalutamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 249. SAMEA Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 250. SAMEA Enzalutamide Drugs Sales by Country (2027-2032) & (K Units) Table 251. SAMEA Enzalutamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 252. SAMEA Enzalutamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 253. Brazil Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 254. Argentina Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 255. Chile Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 256. Colombia Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 257. Peru Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 259. Israel Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 260. UAE Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 261. Turkey Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 262. Iran Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 263. Egypt Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Enzalutamide Drugs Distributors List Table 267. Enzalutamide Drugs Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Enzalutamide Drugs Image Figure 2. Global Enzalutamide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Capsules Image Figure 6. Global Enzalutamide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Enzalutamide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Retail Pharmacies Image Figure 10. Other Image Figure 11. Global Enzalutamide Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Enzalutamide Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Enzalutamide Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Enzalutamide Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Enzalutamide Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Enzalutamide Drugs Sales (2021-2032) & (K Units) Figure 17. Global Enzalutamide Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Enzalutamide Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Enzalutamide Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Enzalutamide Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Enzalutamide Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Enzalutamide Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Enzalutamide Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Enzalutamide Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Enzalutamide Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Enzalutamide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Enzalutamide Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Enzalutamide Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Enzalutamide Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Enzalutamide Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Enzalutamide Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Enzalutamide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Enzalutamide Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Enzalutamide Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Enzalutamide Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Enzalutamide Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Enzalutamide Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Enzalutamide Drugs Revenue Share by Type (2021-2032) Figure 40. North America Enzalutamide Drugs Sales Share by Type (2021-2032) Figure 41. North America Enzalutamide Drugs Revenue Share by Application (2021-2032) Figure 42. North America Enzalutamide Drugs Sales Share by Application (2021-2032) Figure 43. North America Enzalutamide Drugs Revenue Share by Country (2021-2032) Figure 44. North America Enzalutamide Drugs Sales Share by Country (2021-2032) Figure 45. Europe Enzalutamide Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Enzalutamide Drugs Sales Share by Type (2021-2032) Figure 47. Europe Enzalutamide Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Enzalutamide Drugs Sales Share by Application (2021-2032) Figure 49. Europe Enzalutamide Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Enzalutamide Drugs Sales Share by Country (2021-2032) Figure 51. China Enzalutamide Drugs Revenue Share by Type (2021-2032) Figure 52. China Enzalutamide Drugs Sales Share by Type (2021-2032) Figure 53. China Enzalutamide Drugs Revenue Share by Application (2021-2032) Figure 54. China Enzalutamide Drugs Sales Share by Application (2021-2032) Figure 55. Asia Enzalutamide Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Enzalutamide Drugs Sales Share by Type (2021-2032) Figure 57. Asia Enzalutamide Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Enzalutamide Drugs Sales Share by Application (2021-2032) Figure 59. Asia Enzalutamide Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Enzalutamide Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Enzalutamide Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Enzalutamide Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Enzalutamide Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Enzalutamide Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Enzalutamide Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Enzalutamide Drugs Sales Share by Country (2021-2032) Figure 67. Enzalutamide Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Enzalutamide Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Yichang Humanwell Pharmaceutical
  • Shenyang Hongqi Pharmaceutical
  • PuraCap Pharmaceuticals
  • Qilu Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Hansoh Pharmaceutical
  • Zydus
  • Sun Pharma
  • Pfizer
  • Intas Pharmaceuticals
  • Glenmark Pharma
  • Beacon pharma
  • BDR Pharma
  • Astellas Pharma
  • Arechar Healthcare
  • Aprazer Healthcare Pharma
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enzalutamide Drugs Market by Type
  3. 1.2.1 Global Enzalutamide Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Capsules
  6. 1.3 Enzalutamide Drugs Market by Application
  7. 1.3.1 Global Enzalutamide Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Enzalutamide Drugs Market Dynamics
  1. 2.1 Enzalutamide Drugs Industry Trends
  2. 2.2 Enzalutamide Drugs Industry Drivers
  3. 2.3 Enzalutamide Drugs Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enzalutamide Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enzalutamide Drugs Revenue by Region
  3. 3.2.1 Global Enzalutamide Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enzalutamide Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Enzalutamide Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Enzalutamide Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enzalutamide Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enzalutamide Drugs Sales by Region
  9. 3.4.1 Global Enzalutamide Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enzalutamide Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Enzalutamide Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Enzalutamide Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enzalutamide Drugs Revenue by Manufacturers
  2. 4.1.1 Global Enzalutamide Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enzalutamide Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enzalutamide Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enzalutamide Drugs Sales by Manufacturers
  6. 4.2.1 Global Enzalutamide Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enzalutamide Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enzalutamide Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enzalutamide Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enzalutamide Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enzalutamide Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enzalutamide Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Enzalutamide Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enzalutamide Drugs Market CR5 and HHI
  16. 4.8.2 2025 Enzalutamide Drugs Tier 1, Tier 2, and Tier 3
5 Enzalutamide Drugs Market by Type
  1. 5.1 Global Enzalutamide Drugs Revenue by Type
  2. 5.1.1 Global Enzalutamide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enzalutamide Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enzalutamide Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enzalutamide Drugs Sales by Type
  6. 5.2.1 Global Enzalutamide Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enzalutamide Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Enzalutamide Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enzalutamide Drugs Price by Type
6 Enzalutamide Drugs Market by Application
  1. 6.1 Global Enzalutamide Drugs Revenue by Application
  2. 6.1.1 Global Enzalutamide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enzalutamide Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enzalutamide Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enzalutamide Drugs Sales by Application
  6. 6.2.1 Global Enzalutamide Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enzalutamide Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Enzalutamide Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enzalutamide Drugs Price by Application
7 Company Profiles
  1. 7.1 Yichang Humanwell Pharmaceutical
  2. 7.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 7.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 7.1.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio
  6. 7.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 7.2 Shenyang Hongqi Pharmaceutical
  8. 7.2.1 Shenyang Hongqi Pharmaceutical Company Information
  9. 7.2.2 Shenyang Hongqi Pharmaceutical Business Overview
  10. 7.2.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio
  12. 7.2.5 Shenyang Hongqi Pharmaceutical Recent Developments
  13. 7.3 PuraCap Pharmaceuticals
  14. 7.3.1 PuraCap Pharmaceuticals Company Information
  15. 7.3.2 PuraCap Pharmaceuticals Business Overview
  16. 7.3.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio
  18. 7.3.5 PuraCap Pharmaceuticals Recent Developments
  19. 7.4 Qilu Pharmaceutical
  20. 7.4.1 Qilu Pharmaceutical Company Information
  21. 7.4.2 Qilu Pharmaceutical Business Overview
  22. 7.4.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio
  24. 7.4.5 Qilu Pharmaceutical Recent Developments
  25. 7.5 Kelun Pharmaceutical
  26. 7.5.1 Kelun Pharmaceutical Company Information
  27. 7.5.2 Kelun Pharmaceutical Business Overview
  28. 7.5.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio
  30. 7.5.5 Kelun Pharmaceutical Recent Developments
  31. 7.6 Jiangsu Hansoh Pharmaceutical
  32. 7.6.1 Jiangsu Hansoh Pharmaceutical Company Information
  33. 7.6.2 Jiangsu Hansoh Pharmaceutical Business Overview
  34. 7.6.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio
  36. 7.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  37. 7.7 Zydus
  38. 7.7.1 Zydus Company Information
  39. 7.7.2 Zydus Business Overview
  40. 7.7.3 Zydus Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Zydus Enzalutamide Drugs Product Portfolio
  42. 7.7.5 Zydus Recent Developments
  43. 7.8 Sun Pharma
  44. 7.8.1 Sun Pharma Company Information
  45. 7.8.2 Sun Pharma Business Overview
  46. 7.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharma Enzalutamide Drugs Product Portfolio
  48. 7.8.5 Sun Pharma Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Enzalutamide Drugs Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Intas Pharmaceuticals
  56. 7.10.1 Intas Pharmaceuticals Company Information
  57. 7.10.2 Intas Pharmaceuticals Business Overview
  58. 7.10.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio
  60. 7.10.5 Intas Pharmaceuticals Recent Developments
  61. 7.11 Glenmark Pharma
  62. 7.11.1 Glenmark Pharma Company Information
  63. 7.11.2 Glenmark Pharma Business Overview
  64. 7.11.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Glenmark Pharma Enzalutamide Drugs Product Portfolio
  66. 7.11.5 Glenmark Pharma Recent Developments
  67. 7.12 Beacon pharma
  68. 7.12.1 Beacon pharma Company Information
  69. 7.12.2 Beacon pharma Business Overview
  70. 7.12.3 Beacon pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Beacon pharma Enzalutamide Drugs Product Portfolio
  72. 7.12.5 Beacon pharma Recent Developments
  73. 7.13 BDR Pharma
  74. 7.13.1 BDR Pharma Company Information
  75. 7.13.2 BDR Pharma Business Overview
  76. 7.13.3 BDR Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 BDR Pharma Enzalutamide Drugs Product Portfolio
  78. 7.13.5 BDR Pharma Recent Developments
  79. 7.14 Astellas Pharma
  80. 7.14.1 Astellas Pharma Company Information
  81. 7.14.2 Astellas Pharma Business Overview
  82. 7.14.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Astellas Pharma Enzalutamide Drugs Product Portfolio
  84. 7.14.5 Astellas Pharma Recent Developments
  85. 7.15 Arechar Healthcare
  86. 7.15.1 Arechar Healthcare Company Information
  87. 7.15.2 Arechar Healthcare Business Overview
  88. 7.15.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Arechar Healthcare Enzalutamide Drugs Product Portfolio
  90. 7.15.5 Arechar Healthcare Recent Developments
  91. 7.16 Aprazer Healthcare Pharma
  92. 7.16.1 Aprazer Healthcare Pharma Company Information
  93. 7.16.2 Aprazer Healthcare Pharma Business Overview
  94. 7.16.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio
  96. 7.16.5 Aprazer Healthcare Pharma Recent Developments
  97. 7.17 Abbott Laboratories
  98. 7.17.1 Abbott Laboratories Company Information
  99. 7.17.2 Abbott Laboratories Business Overview
  100. 7.17.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abbott Laboratories Enzalutamide Drugs Product Portfolio
  102. 7.17.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Enzalutamide Drugs Market Size by Type
  2. 8.1.1 North America Enzalutamide Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Enzalutamide Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Enzalutamide Drugs Price by Type (2021-2032)
  5. 8.2 North America Enzalutamide Drugs Market Size by Application
  6. 8.2.1 North America Enzalutamide Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Enzalutamide Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Enzalutamide Drugs Price by Application (2021-2032)
  9. 8.3 North America Enzalutamide Drugs Market Size by Country
  10. 8.3.1 North America Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enzalutamide Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Enzalutamide Drugs Market Size by Type
  2. 9.1.1 Europe Enzalutamide Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enzalutamide Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Enzalutamide Drugs Price by Type (2021-2032)
  5. 9.2 Europe Enzalutamide Drugs Market Size by Application
  6. 9.2.1 Europe Enzalutamide Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enzalutamide Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Enzalutamide Drugs Price by Application (2021-2032)
  9. 9.3 Europe Enzalutamide Drugs Market Size by Country
  10. 9.3.1 Europe Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enzalutamide Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Enzalutamide Drugs Market Size by Type
  2. 10.1.1 China Enzalutamide Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Enzalutamide Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Enzalutamide Drugs Price by Type (2021-2032)
  5. 10.2 China Enzalutamide Drugs Market Size by Application
  6. 10.2.1 China Enzalutamide Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Enzalutamide Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Enzalutamide Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enzalutamide Drugs Market Size by Type
  2. 11.1.1 Asia Enzalutamide Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enzalutamide Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Enzalutamide Drugs Price by Type (2021-2032)
  5. 11.2 Asia Enzalutamide Drugs Market Size by Application
  6. 11.2.1 Asia Enzalutamide Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enzalutamide Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Enzalutamide Drugs Price by Application (2021-2032)
  9. 11.3 Asia Enzalutamide Drugs Market Size by Country
  10. 11.3.1 Asia Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enzalutamide Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enzalutamide Drugs Market Size by Type
  2. 12.1.1 SAMEA Enzalutamide Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enzalutamide Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enzalutamide Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Enzalutamide Drugs Market Size by Application
  6. 12.2.1 SAMEA Enzalutamide Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enzalutamide Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enzalutamide Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Enzalutamide Drugs Market Size by Country
  10. 12.3.1 SAMEA Enzalutamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enzalutamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enzalutamide Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enzalutamide Drugs Value Chain Analysis
  2. 13.1.1 Enzalutamide Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enzalutamide Drugs Production Mode & Process
  6. 13.2 Enzalutamide Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enzalutamide Drugs Distributors
  9. 13.2.3 Enzalutamide Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst